Not only did I not know that longtime local brewery Novo Brazil had opened a new spot in the Mission Valley Mall, but I also ...

Booster Therapeutics has launched with $15 million in seed financing and a mission to take on the current crop of targeted ...

According to Research by SNS Insider, The Human Insulin Market is projected to grow at a CAGR of 3.4%, fueled by regulatory reforms and the launch of biosimilars.Pune, Oct. 10, 2024 (GLOBE NEWSWIRE) - ...

Novo Nordisk’s stock declined 12% in the past month. Wegovy's sales growth stays under pressure. Read why I'm neutral on NVO ...

Novo Nordisk has launched the Childhood Obesity Prevention Initiative, aimed at combating rising obesity rates among children in underserved urban communities across six cities worldwide. Backed by an ...

Novo Nordisk has launched the Childhood Obesity Prevention Initiative, aimed at combating rising obesity rates among children ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

Alongside the settlement, Novo and Viatris have asked the U.S. Patent and Trademark Office to terminate its review of the ...

The initiative will launch in six cities across five continentsInterventions aim to increase physical activity and healthy ...

The global continuous glucose monitoring systems (CGMS) market was valued at approximately USD 6,626.6 million in 2021 and is expected to grow to USD 31,708.2 million by 2032, with a CAGR of 17.0% ...

Novo Nordisk plans to invest approximately $158 million into revamping its Montes Claros manufacturing facility in Minas Gerais, Brazil, Bloomberg reported Oct. 5.

Bristol Myers Squibb's schizophrenia drug, which received FDA approval last week, took a long and winding road to get there. Three decades ago, Eli Lilly developed the drug's forerunner, xanomeline, ...